News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
United States
Policy
FDA Puts Clinical Hold on Three CARsgen Therapeutics CAR-T Candidates
The regulator placed the clinical hold on the Chinese biotech’s trio of CAR-T cell therapy candidates after an inspection of its Durham, North Carolina manufacturing facility.
December 15, 2023
·
2 min read
·
Tyler Patchen
Job Trends
New Lilly Manufacturing Plant to Bring 600 Jobs to North Carolina
Eli Lilly and Company announced plans to build a new manufacturing plant in Concord, North Carolina.
January 31, 2022
·
2 min read
·
Mark Terry
PRESS RELEASES
Press Releases
Mineralys Therapeutics to Announce Third Quarter 2025 Financial Results and Host Conference Call on Monday, November 10, 2025
November 4, 2025
·
1 min read
Press Releases
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences - November 3, 2025
November 4, 2025
·
2 min read
Press Releases
NanoViricides to Present at the Spartan Capital Investor Conference 2025 in New York City Today, November 3rd
November 4, 2025
·
14 min read
Press Releases
Tenon Medical, Inc. Announces Timing of Third Quarter 2025 Financial Results
November 4, 2025
·
2 min read
Press Releases
Aurinia Pharmaceuticals to Report Financial Results for the Three and Nine Months Ended September 30, 2025 and Provide Update on Recent Business Progress on November 4, 2025
November 4, 2025
·
1 min read
Press Releases
AIM ImmunoTech Announces European Patent Office Grants Patent Covering Ampligen® (Rintatolimod) for Use in the Treatment of the Post-COVID Condition of Fatigue
November 4, 2025
·
3 min read
Press Releases
Immix Biopharma’s NXC-201 NEXICART-2 Clinical Trial Results Selected for Oral Presentation at ASH 2025
November 4, 2025
·
5 min read
Press Releases
IRADIMED CORPORATION Reports Record Third Quarter 2025 Financial Results
November 4, 2025
·
22 min read
Press Releases
Achieve Life Sciences Meets Key Milestones Advancing Cytisinicline NDA for Smoking Cessation
November 4, 2025
·
6 min read
Press Releases
Femasys Secures FDA Approval to Advance Final FemBloc® Trial Phase and $12 Million Financing, with Potential to Reach $58 Million
November 4, 2025
·
9 min read
Press Releases
Amarin To Present New Analyses Affirming Robustness of Data from REDUCE-IT and Additional Mechanisms of Action of Eicosapentaenoic Acid (EPA) at American Heart Association (AHA) Scientific Sessions 2025
November 4, 2025
·
8 min read
Press Releases
Lilly plans to build a new $3 billion facility to boost oral medicine manufacturing capacity in Europe for patients worldwide
November 4, 2025
·
6 min read
Press Releases
Eisai Demonstrates Commitment to Advanced Endometrial Cancer Care at IGCS 2025
November 4, 2025
·
25 min read
Press Releases
INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults
November 4, 2025
·
8 min read
Press Releases
Advita Ortho Launches to Advance Patient Lives through Orthopedic Innovation
November 4, 2025
·
6 min read
Press Releases
Alcresta Therapeutics Announces FDA Clearance for Expanded Use of RELiZORB® (iMMOBILIZED LIPASE) Cartridge for Neonates and Infants
November 4, 2025
·
3 min read
Press Releases
CREATE Medicines to Present Late-Breaking Clinical Data on MT-302 at the Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting
November 4, 2025
·
2 min read
Press Releases
Servier Announces Positive Findings from Longer-Term Analysis of the Phase 3 INDIGO Trial Showing Continued Durable Treatment Effect of VORANIGO® (vorasidenib) Published in The Lancet Oncology
November 4, 2025
·
12 min read
Press Releases
Indivior Presents New Real-World Evidence at AMCP Nexus 2025 Demonstrating Clinical and Economic Benefits of Adherence to Monthly Injectable Buprenorphine
November 4, 2025
·
7 min read
Press Releases
Matica Bio, a CDMO Leader in Oncolytic Virus Manufacturing, Partners with Calidi Biotherapeutics to Advance Calidi’s Project Toward IND
November 4, 2025
·
4 min read